This is an old revision of this page, as edited by Beetstra (talk | contribs) at 12:38, 24 November 2011 (Saving copy of the {{drugbox}} taken from revid 456816569 of page Miltefosine for the Chem/Drugbox validation project (updated: 'CAS_number').). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 12:38, 24 November 2011 by Beetstra (talk | contribs) (Saving copy of the {{drugbox}} taken from revid 456816569 of page Miltefosine for the Chem/Drugbox validation project (updated: 'CAS_number').)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)This page contains a copy of the infobox ({{drugbox}}) taken from revid 456816569 of page Miltefosine with values updated to verified values. |
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
Routes of administration | Oral |
ATC code | |
Pharmacokinetic data | |
Bioavailability | High |
Elimination half-life | 6 to 8 days and 31 days |
Identifiers | |
IUPAC name
| |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
Chemical and physical data | |
Formula | C21H46NO4P |
Molar mass | 407.568 g/mol g·mol |
3D model (JSmol) | |
SMILES
| |
InChI
| |
(what is this?) (verify) |
- Dorlo TP, van Thiel PP, Huitema AD, Keizer RJ, de Vries HJ, Beijnen JH, de Vries PJ (2008). "Pharmacokinetics of miltefosine in Old World cutaneous leishmaniasis patients". Antimicrob Agents Chemother. 52 (8): 2855–60. doi:10.1128/AAC.00014-08. PMC 2493105. PMID 18519729.
{{cite journal}}
: CS1 maint: multiple names: authors list (link)